OBJECTIVE: The purpose of this review is to ascertain the indications, techniques, and the associated morbidity with the use of Bakri balloon. MATERIAL AND METHODS: A literature search using the PubMed database was conducted from 2001 to 2013. We calculated 95% confidence intervals (CIs) for complications. RESULTS: We identified 12 publications that met the inclusion criteria. Four reports provided the frequency of Bakri use during the study period, with the overall rate being 0.20% (138/69, 174; 95% CI, 0.17-0.25%). Two-thirds of use followed cesarean delivery (67%; 182/273). Uterine atony was specified as the underlying etiology of postpartum hemorrhage in 75% (9/12) of publication. The rate of balloon displacement was 10% (95% CI, 6-16%) and need for transfusion, 43% (95% CI, 32-55%). Hysterectomy was undertaken in 6% (95% CI, 4-10%). CONCLUSIONS: There is a paucity of publications on Bakri balloon. Before its utilization is recommended in guidelines, a randomized clinical trial comparing uterotonics alone versus with balloon is warranted. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
OBJECTIVE: The purpose of this review is to ascertain the indications, techniques, and the associated morbidity with the use of Bakri balloon. MATERIAL AND METHODS: A literature search using the PubMed database was conducted from 2001 to 2013. We calculated 95% confidence intervals (CIs) for complications. RESULTS: We identified 12 publications that met the inclusion criteria. Four reports provided the frequency of Bakri use during the study period, with the overall rate being 0.20% (138/69, 174; 95% CI, 0.17-0.25%). Two-thirds of use followed cesarean delivery (67%; 182/273). Uterine atony was specified as the underlying etiology of postpartum hemorrhage in 75% (9/12) of publication. The rate of balloon displacement was 10% (95% CI, 6-16%) and need for transfusion, 43% (95% CI, 32-55%). Hysterectomy was undertaken in 6% (95% CI, 4-10%). CONCLUSIONS: There is a paucity of publications on Bakri balloon. Before its utilization is recommended in guidelines, a randomized clinical trial comparing uterotonics alone versus with balloon is warranted. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Authors: H A Anger; R Dabash; J Durocher; N Hassanein; S Ononge; L J Frye; A Diop; S B Beye; G Burkhardt; E Darwish; M C Ramadan; J Kayaga; D Charles; A Gaye; M Eckardt; B Winikoff Journal: BJOG Date: 2019-09-18 Impact factor: 6.531
Authors: Francisco Javier Ruiz Labarta; María Pilar Pintado Recarte; Laura Joigneau Prieto; Coral Bravo Arribas; Julia Bujan; Miguel A Ortega; Juan A De León-Luis Journal: Healthcare (Basel) Date: 2021-03-08